Assessing the value of treatment for diabetes to patients, the healthcare system, and wider society

Statement 30 May 2023

Innovative pharmaceutical industry contributes to discussions on universal health coverage and health security during 76th World Health Assembly

On 30 May, IFPMA issued a statement summarizing their contributions to universal health coverage and health security at the 76th World Health Assembly.

Individual statement at WHA76 on agenda items 13.1 and 13.2

On 26 May, IFPMA provided a WHA76 statement on agenda items 13.1: Reorienting health systems to primary health care as a resilient foundation for universal health coverage and preparations for a high-level meeting of the United Nations General Assembly on universal health coverage and 13.2: Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases, and mental health.

Collaborating for Global Health Progress flyer

Discover how the innovative pharmaceutical industry works with partners to advance the SDGs